At present, several types of modified LDL have been shown to occur in human blood. Curtiss and Witztum15 have demonstrated the presence of nonenzymatically glycosylated LDL in the blood of hyperglycemic diabetic patients. We have recently shown that LDL isolated from the blood of atherosclerotic patients was able to induce intracellular lipid accumulation in cultured aortic cells1617 and differed from native LDL by a lower content of sialic acid; i.e., it appeared to be a desialylated lipoprotein."11,2 Lipoprotein (a), which differs from LDL by the presence of an additional apoprotein is also considered to play an important role in the deposition of intracellular lipids.18"19 In the present study, we demonstrated that in vivo modified LDL caused lipid accumulation in cultured human intimal smooth muscle cells and monocytes. We tested the hypothesis that modified lipoprotein aggregates but not single particles caused intracellular lipid accumulation. To this end we showed that 1) in vivo modified LDLs were able to form aggregates, 2) these aggregates caused the accumulation of cholesteryl esters in cultured cells, and 3) the removal of aggregates from LDL preparation prevented the intracellular cholesteryl ester accumulation. We also attempted to examine the mechanism underlying the interaction between LDL aggregates and vascular cells. Preparation of Lipoproteins LDL (1.019-1.050 g/cm') was isolated by sequential ultracentrifugation in a preparative ultracentrifuge after appropriate adjustment of density with solid NaBr20 from the pooled blood of 12 healthy subjects, from 12 patients with coronary heart disease (CHD) with angiographically documented stenosis of coronary arteries, and from 12 non-insulin-dependent diabetic patients. The degree of lipoprotein aggregation was evaluated by the method based on the analysis of light transmission fluctuations in LDL suspension.29 The relative dispersion of the optical density fluctuations caused by random changes in the number of particles in the optical channel reflects the deviations in their average size, i.e., the degree of aggregation. The optical density fluctuations were measured using a semiconductor laser with collimating optics (wavelength, 860 nm). The aggregate size was determined by methods of quasielastic laser scattering on an Autosizer 2 (Malvern Instrument, UK).
Recently we have reported that in vitro modified LDL forms aggregates under the conditions of cell culture.14 A direct correlation between the degree of aggregation of oxidized, glycosylated, desialylated, or malondialdehyde-treated LDL and an increase in intracellular cholesteryl ester content was established. Furthermore, the removal of aggregates from modified LDL preparations by filtration resulted in a marked *modified lipoproteins * lipoprotein aggregation * suppression of lipid accumulation in cultured cells. These findings allowed us to conclude that aggregation of in vitro modified LDL is a necessary step in intracellular lipid deposition.
At present, several types of modified LDL have been shown to occur in human blood. Curtiss and Witztum15 have demonstrated the presence of nonenzymatically glycosylated LDL in the blood of hyperglycemic diabetic patients. We have recently shown that LDL isolated from the blood of atherosclerotic patients was able to induce intracellular lipid accumulation in cultured aortic cells1617 and differed from native LDL by a lower content of sialic acid; i.e., it appeared to be a desialylated lipoprotein."11,2 Lipoprotein (a), which differs from LDL by the presence of an additional apoprotein is also considered to play an important role in the deposition of intracellular lipids. 18"19 In the present study, we demonstrated that in vivo modified LDL caused lipid accumulation in cultured human intimal smooth muscle cells and monocytes. We tested the hypothesis that modified lipoprotein aggregates but not single particles caused intracellular lipid accumulation. To this end we showed that 1) in vivo modified LDLs were able to form aggregates, 2) these aggregates caused the accumulation of cholesteryl esters in cultured cells, and 3) the removal of aggregates from LDL preparation prevented the intracellular cholesteryl ester accumulation. We also attempted to examine the mechanism underlying the interaction between LDL aggregates and vascular cells. Preparation of Lipoproteins LDL (1.019-1.050 g/cm') was isolated by sequential ultracentrifugation in a preparative ultracentrifuge after appropriate adjustment of density with solid NaBr20 from the pooled blood of 12 healthy subjects, from 12 patients with coronary heart disease (CHD) with angiographically documented stenosis of coronary arteries, and from 12 non-insulin-dependent diabetic patients. The degree of lipoprotein aggregation was evaluated by the method based on the analysis of light transmission fluctuations in LDL suspension. 29 The relative dispersion of the optical density fluctuations caused by random changes in the number of particles in the optical channel reflects the deviations in their average size, i.e., the degree of aggregation. The optical density fluctuations were measured using a semiconductor laser with collimating optics (wavelength, 860 nm). The aggregate size was determined by methods of quasielastic laser scattering on an Autosizer 2 (Malvern Instrument, UK).
Materials and Methods
For the analysis of lipoprotein aggregation, native and modified lipoproteins were passed through a Sepharose CL-2B column (25 x 0.6 cm) at a flow rate of 0.15 ml/mnin. Fractions (0.30 ml) were collected, and total cholesterol content was determined in each fraction.
Examination of Lipoprotein-Lipoprotein Interactions
Ninety-six-well microtiter plates were precoated with freshly prepared native and modified lipoproteins (1 ,ug LDL protein per well) and incubated for 1 hour at 37°C. Then the wells were washed with 0.2% bovine serum albumin in PBS, and 0.01-100 ,g/ml`PI-LDL was added to each well. After a 1-hour incubation at 370C, the wells were washed thoroughly with PBS, and radioactivity was measured.
Cell Culture
Subendothelial cells for culture were isolated from grossly normal intima by dispersion of human aortic tissue with 0.15% collagenase and suspended in the growth medium containing Medium 199, 10% fetal calf serum, 2 mM L-glutamine, and antibiotics. Cells were seeded into 24-well tissue culture plates at a density of 2-4x 104 cells per 1 cm2 of growth area. 30 The cells were cultured at 37°C in a humidified CO2 incubator (95% air-5% CO2). The PhL, phospholipids; Cho, free cholesterol; TG, triglycerides; CE, cholesteryl esters; TBA, thiobarbituric acid; apoB, apolipoprotein B; LDL, low density lipoprotein; CHD, coronary heart disease.
by the method of Siedel et al3 using Boehringer Mannheim kits. Lipids were extracted from lipoproteins with a mixture of chloroform: methanol (2:1 vol/vol) according to Folch et al. 34 Phospholipids and neutral lipids were separated by thin-layer chromatography and measured by scanning densitometry.30
Examination of Lipoprotein Uptake and Degradation
Cells were incubated with labeled lipoprotein or labeled lipoprotein aggregates for 6 hours at 37°C. After incubation, an aliquot of the culture medium was taken to determine LDL degradation by the presence of the trichloroacetic acid-soluble (noniodide) 1251.3 To determine the '1I uptake, cells were rinsed three times with PBS containing 0.2% albumin and seven times with PBS alone, after which they were dissolved in 0.1N NaOH to measure 'I radioactivity.
Statistical Analysis
The significance of differences of group mean values was evaluated by multiple t test of one-way analysis of variance using a BMDP statistical program package. 35 The Bonferroni method was used to compare the experimental groups with the control group.36 Table 1 shows the characteristics of lipoprotein preparations examined in the present study. The protein and lipid compositions of LDLs obtained from healthy subjects and CHD or diabetic patients were essentially similar. There was no significant difference in the content of TBA-reactive substance between LDL preparations obtained from healthy subjects and from CHD and diabetic patients. The sialic acid content in the LDL of CHD patients was threefold lower compared with that in the LDL of healthy subjects. A high fructosyl lysine content in the LDL of diabetic patients that was due to enhanced glycosylation of LDL was also found (see Table 1 ).
Results

Characterization of Lipoprotein Preparations
In healthy subjects desialylation of LDL by treatment with agarose-linked neuraminidase lowered the sialic acid content to 29% of the initial level and had no effect on other parameters. Fructosyl lysine content was twofold higher, and TBA-reactive substance content was not changed in glycosylated in vitro LDL as compared with native LDL (Table 1) .
As for lipoprotein (a), the protein/lipid ratio and the ratios between the major lipid classes were similar to those in native LDL. The sialic acid content was sevenfold higher in lipoprotein (a) than in donors' LDL, and the TBA-reactive substance content did not differ significantly from that of LDL.
Effect of Lipoproteins on Intracellular
Lipid Accumulation Figure 1 illustrates the effects of lipoproteins on the cholesteryl ester content in smooth muscle cells cul- Figure 2 illustrates the kinetics of average particle size increase for lipoproteins incubated at 37°C in Medium 199 containing 5% lipoprotein-deficient serum in the absence of cultured cells. With native LDL isolated from the blood of healthy subjects, there was no appreciable change in the average size of particles up to 24 hours of incubation ( Figure 2A ). In contrast, with LDL from CHD or diabetic patients and with lipoprotein (a), the significant increase of the average particle size occurred within 6 hours of incubation, reflecting LDL aggregation ( Figures 2B, 2C , and 2F); similar effects were observed for desialylated ( Figure 2D ) or glycosylated LDL ( Figure 2E ). We failed to detect any further increase of LDL aggregation when incubated at 37°C in the presence of intimal smooth muscle cells (Figure 2) Preparations of freshly modified LDL were filtered through 0.22-pum filters and preincubated for 6 hours in Medium 199 containing 5% lipoprotein-deficient serum (0.5 mg apolipoprotein B/ml). After preincubation, lipoprotein preparations were carefully filtered through 0.1-j.gm, 0.22-um, and 0.45-jum filters and added to cells at a concentration of 0.1 mg/ml. After 6 hours of incubation, cells were rinsed, and their CE content was measured. *p<0.01 vs. control.
Experiments with a continuous filtration of the culture medium containing modified LDL were also performed. A schematic diagram of the apparatus for continuous filtration is shown in Figure 5 . Medium 199 containing 5% lipoprotein-deficient serum and LDL preparations were filtered (pore size, 0.1 ,um) for the whole incubation period at a flow rate of 0.5 ml/min. Continuous filtration of the culture medium abolished cholesteryl ester accumulation in cultured intimal smooth muscle cells, whereas the cholesteryl ester content of cells incubated with lipoprotein (a), modified LDL, and patients' LDL in the absence of continuous filtration increased approximately twofold ( Figure 6 ). induced a fourfold to fivefold rise in intracellular cholesteryl ester content. Aggregates of in vitro desialylated and glycosylated LDL produced the same effect (Table  4) . Similar results were obtained for cultured human peripheral blood monocytes (Table 5 ).
Uptake and Degradation of LDL Aggregates
The uptake of aggregates of desialylated or glycosylated`PI-LDL by smooth muscle cells was fivefold to sevenfold higher than the uptake of native LDL or aggregate-free LDL preparations (Table 6) . Interestingly, the uptake of modified LDL after the removal of aggregates was nearly the same as that of native LDL.
Degradation of aggregates of modified`25P-LDL by cultured smooth muscle cells was approximately fourfold to fivefold greater than that of native LDL or aggregate-free LDL preparations (Table 6 ). Degradation of aggregate-free preparations of modified LDL was similar to that of native lipoproteins.
Similar results were obtained with cultured monocytes (Table 6 ). The uptake of aggregates of desialylated and glycosylated`251-LDL by intimal cells was threefold to fourfold greater than that of native LDL. The degradation rate for aggregated LDL by monocytes was twofold to fourfold greater than that for native LDL (Table 6) .
To determine whether the receptors for native and modified LDL were involved in the interaction between cells and LDL aggregates, we examined the effect of excess of native unlabeled LDL on uptake and degradation of 125I-LDL aggregates. A 20-fold excess of native or acetylated unlabeled LDL had no effect on uptake and degradation of 15I-LDL aggregates (Table 7) . On the other hand, the addition of a 20-fold excess of aggregated unlabeled LDLs resulted in a notable de- Freshly filtered lipoprotein preparations were preincubated for 6 hours at 37°C. Aggregated and nonaggregated modified lipoproteins were separated by gel filtration on a Sepharose CL-2B column (1.6x 90 cm) at a flow rate of 1.5 ml/min. Fractions of aggregated and nonaggregated lipoproteins were pooled and examined (concentration, 100 ,g/ml) for their ability to induce cholesteryl ester accumulation in cultured smooth muscle cells from grossly normal human aortic intima.
*p<0.05 vs. control value. (Table 7) , without any significant change in the uptake and degradation rate for the native LDL of healthy subjects.
Marked suppression (twofold to threefold) of uptake and degradation of`251-LDL aggregates by latex beads also confirmed the crucial role of phagocytosis in these processes in the case of cultured smooth muscle cells and monocytes (Table 7) .
The aggregate-cell interaction is probably independent of the type of LDL modification. This is confirmed by the fact that the uptake of modified LDL aggregates can be suppressed by an excess of aggregated LDL modified in any other manner ( Figure 7) .
Discussion
In the present study we have demonstrated that the glycosylated LDL of diabetic patients, desialylated LDL shows the amount of aggregates to be approximately two orders lower than the number of native LDL particles. One can suggest that the lower rate of degradation of native`PI-LDL is due to the aggregateproduced inhibition of LDL metabolism within the cell rather than to occupation of the major proportion of B,E-receptors by aggregates.
As other evidence of aggregate uptake via B,Ereceptor, Khoo et 
